Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications risk reducing surgery cancer related distress among female brca1 brca2 mutation
… of project management, portfolio management, and project-related support roles. Ms Jimenez has expertise in managing clinical research studies related to the acquisition and analysis of clinical data …
Canadian Association for Population Therapeutics Conference 2022 Share on: Monday, October 17 - Tuesday, October 18, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the 2022 Canadian Association for …
… Anam Khan Pharmacoepidemiology and Risk Management Waltham, Massachusetts, USA PhD, Epidemiology … Pharmacoepidemiologist in the Pharmacoepidemiology and Risk Management group with RTI-HS. Dr. Khan has over 7 years …
How Do We Get Drug Labeling Based on Patient Reported Outcomes? With Ari Gnanasakthy , MBA, MSc, Principal Scientist, Patient-Centered Outcomes Assessment at RTI Health Solutions. Transcript A frequent request we receive from clients relates to labeling, …
… researchers across therapeutic fields to plan and develop publications highlighting their work. Key research fields and … in a molecular oncology lab where he became more versed in cancer diagnostics and prognostics. …
Knowledgebase - ICER Evaluations Image Image Image Knowledgebase KB Image Image KB …
… progress, and adeptly addressing and identifying data-related issues. Proficient in utilizing various statistical …
40th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) Share on: Monday, May 9 - Friday, May 13, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the 40th Annual Meeting …
… treatment and vaccine development Although COVID-19-related disruptions to the pharmaceutical supply chain and to …
HTA and Reimbursement Considerations for Orphan Drugs in European Markets HTA and Reimbursement Considerations for Rare Diseases in European Markets: What Are the Implications for Manufacturers? Heyes A, McBride D, Pearson I, Copley-Merriman C …